ADAMTS13 deficiency, an important cause of thrombocytopenia during pregnancy

International Journal of Obstetric Anesthesia

Volumn 18, Issue 1, 2009, Pages 73-77

  Kato, R ^a   Shinohara, A ^a   Sato, J ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; Cesarean delivery; Pregnancy; Spinal anesthesia; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; BUPIVACAINE; EPHEDRINE; FENTANYL; FRESH FROZEN PLASMA; MORPHINE; PHENYLEPHRINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FETUS DEATH; HELLP SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIMIGRAVIDA; SOLUTIO PLACENTAE; SPINAL ANESTHESIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADAM PROTEINS; ADULT; ANESTHESIA, OBSTETRICAL; ANESTHESIA, SPINAL; CESAREAN SECTION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 57749179938     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2008.07.009     Document Type: Article

References (12)

1. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
2. Mannucci P.M. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome: much progress and many remaining issues. Haematologica 92 (2007) 878-880
3. Peyvandi F., Lavoretano S., Palla R., et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 93 (2008) 232-239
4. George J.N. Evaluation and management of patients with thrombotic thrombocytopenic purpura. J Intensive Care Med 22 (2007) 82-91
5. George J.N. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 10 (2003) 339-344
6. Sanchez-Luceros A., Farias C.E., Amaral M.M., et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92 (2004) 1320-1326
7. Lattuada A., Rossi E., Calzarossa C., Candolfi R., and Mannucci P.M. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 88 (2003) 1029-1034
8. Mannucci P.M., and Peyvandi F. TTP and ADAMTS13: When is testing appropriate?. Hematology Am Soc Hematol Educ Program 2007 (2007) 121-126
9. Vesely S.K., Li X., McMinn J.R., Terrell D.R., and George J.N. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44 (2004) 1149-1158
10. Franchini M., Montagnana M., Targher G., and Lippi G. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost 33 (2007) 787-797
11. George J.N. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354 (2006) 1927-1935
12. Rehberg J.F., Briery C.M., Hudson W.T., Bofill J.A., and Martin Jr. J.N. Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy. Obstet Gynecol 108 (2006) 817-820